CyberSAR leverages advanced Al technology to intelligently analyze vast volumes of literature and patent data, automatically extracting key information with precision. It intelligently comprehends and extracts R&D data, including targets, molecular structures, and biological activities. This empowers rapid assessment of drug potential and identification of development targets.
Unlock precise decisions in navigating chemical space with a deep grasp of SAR data. Harnessing the DGL virtual compound library and cutting-edge algorithms, CyberSAR offers one-click molecular generation, empowering medicinal chemists in drug design. Drug-like molecules optimized with Al flows to improve efficacy, affinity, and selectivity.
Empowered by Al, CyberSAR clusters 1 million molecules, revealing correlations in target, molecular core, structure, and activity/ADMET. Rapidly analyzing Structure-Activity Relationships (SAR), it provides a comprehensive view of millions of compounds by linking chemical structures to biological, pharmacological, and therapeutic insights.
CyberSAR extracts in vitro/in vivo biological activity, ADME experimental protocols, which related to molecules, accelerating the design, screening and evaluation of specific experimental protocols by medicinal chemists.
